Clinical discussion of pih

Reading File

Finding Sources

Searching PubMed

pregnancy induced hypertension preeclampsia management

Reading File

Loading Image

I now have very rich material from multiple authoritative textbooks. Let me compile the full clinical discussion.

Pregnancy-Induced Hypertension (PIH): A Clinical Discussion

1. Definition and Classification

PIH (Pregnancy-Induced Hypertension) is an umbrella term for hypertensive disorders that arise during pregnancy. Hypertension affects up to 8-10% of all pregnancies and is classified into several distinct entities:

Category	Definition
Gestational Hypertension	New BP ≥ 140/90 mmHg after 20 weeks gestation; resolves postpartum; no proteinuria
Preeclampsia	Gestational hypertension + proteinuria (>300 mg/24 hr) or end-organ damage after 20 weeks
Eclampsia	Seizures superimposed on preeclampsia
Superimposed Preeclampsia	Preeclampsia developing in a woman with pre-existing chronic hypertension
Chronic/Coincidental Hypertension	Present before pregnancy or persists >6 weeks postpartum

Rosen's Emergency Medicine, 10th Ed.
Creasy & Resnik's Maternal-Fetal Medicine

2. Epidemiology

Hypertensive disorders of pregnancy occur at approximately 85 per 1,000 deliveries in the United States.
Preeclampsia specifically affects 3-7% of pregnancies; eclampsia has become rare with modern care.
Nulliparity accounts for the largest population-attributable fraction (~32%) of preeclampsia risk.

Risk Factors:

Nulliparity (greatest single risk factor)
Extremes of maternal age (<20 and >35 years)
Prior history of preeclampsia
Chronic hypertension (25% risk of superimposed preeclampsia)
Pregestational diabetes mellitus (20% overall risk; up to 70% with classes F/R)
Chronic renal failure
Antiphospholipid syndrome
Connective tissue disorders (SLE)
Twin/multiple gestation, molar pregnancy
Obesity, hypercholesterolemia
Family history of PIH
In vitro fertilization
Creasy & Resnik's Maternal-Fetal Medicine

3. Pathophysiology

This is the most complex and fascinating aspect of PIH. The central defect is inadequate trophoblastic invasion of the spiral arteries.

3a. Normal Placentation vs. PIH

Spiral artery remodeling - normal vs. preeclampsia

Normal pregnancy (left): Trophoblasts deeply invade spiral arteries, transforming them into wide, low-resistance sinusoids with high blood flow. Preeclampsia (right): Trophoblastic invasion fails; arteries remain narrow and coiled, resulting in placental ischemia. (Guyton & Hall Textbook of Medical Physiology)

In normal pregnancy, trophoblasts invade the spiral arteries of the uterine endometrium, remodeling their musculoelastic walls into wide vascular sinusoids with high flow and low resistance. In preeclampsia, this remodeling fails. The arteries retain their musculoelastic walls, remain narrow, and produce chronic placental hypoperfusion.

3b. The Cascade from Placental Ischemia to Systemic Disease

Placental ischemia triggers release of circulating vasoactive and anti-angiogenic factors into the maternal bloodstream:

Anti-angiogenic proteins - Soluble FMS-like tyrosine kinase 1 (sFlt-1) and soluble endoglin are released by the ischemic placenta. These antagonize the effects of VEGF and TGF-β, causing widespread maternal endothelial dysfunction.
Pro-inflammatory cytokines - TNF-α and IL-6 levels rise, amplifying vascular injury.
Prostanoid imbalance - Reduced endothelial production of vasodilators (prostacyclin/PGI₂, PGE₂) combined with increased vasoconstrictor thromboxane A₂ results in systemic vasoconstriction.
Endothelial dysfunction - Results in vascular hyperreactivity, increased peripheral resistance, and microangiopathy across organs.

The net hemodynamic pattern evolves:

Early: Elevated cardiac output, then rising peripheral resistance
Late: Cardiac output drops as peripheral resistance markedly increases
Robbins & Kumar Basic Pathology; Guyton & Hall Medical Physiology

3c. Consequences of Endothelial Dysfunction

Organ/System	Effect
Kidneys	Decreased RBF and GFR, glomerular endotheliosis, proteinuria, oliguria
Brain	Cerebral vasospasm, encephalopathy, seizures (eclampsia), intracranial hemorrhage
Liver	Periportal hemorrhage, hepatocellular necrosis, RUQ pain
Placenta	Infarction, retroplacental hemorrhage, fetal growth restriction
Coagulation	Hypercoagulability, thrombocytopenia, possible DIC
Cardiovascular	Systemic vasoconstriction, hypertension, pulmonary edema

4. Clinical Features

4a. Preeclampsia

Classic triad: Hypertension + Proteinuria + Edema (after 20 weeks)

BP ≥ 140/90 mmHg on two occasions, at least 4 hours apart
Proteinuria >300 mg/24 hr (or protein:creatinine ratio ≥0.3)
Edema (particularly face and hands; non-dependent edema)
Symptoms: headache, visual disturbances (scotomata, blurring), epigastric/RUQ pain, nausea

4b. Severe Preeclampsia Features

Any of:

BP ≥ 160/110 mmHg (persistent ≥15 min)
Thrombocytopenia (<100,000/µL)
Renal insufficiency (creatinine >1.1 mg/dL)
Impaired liver function (AST/ALT ≥2x upper limit)
Pulmonary edema
New-onset headache unresponsive to medication
Visual disturbances

4c. HELLP Syndrome

A particularly severe variant (~10% of severe preeclampsia):

Hemolysis (microangiopathic hemolytic anemia)
Elevated Liver enzymes (ALT/AST >70 U/L)
Low Platelets (<100,000/mL)
Can be complicated by DIC
High mortality if not recognized promptly

4d. Eclampsia

Generalized tonic-clonic seizures in a patient with signs/symptoms of preeclampsia
Can occur antepartum, intrapartum, or postpartum (20% of eclampsia occurs >48 hours after delivery)
Progression from preeclampsia to eclampsia is unpredictable and can be rapid
Rosen's Emergency Medicine; Goodman & Gilman's Pharmacology

5. Pathological (Morphological) Changes

Placental:

Numerous placental infarcts
Retroplacental hemorrhage
Ischemic changes of villi (excess syncytial knot formation)
Abnormal decidual vessels with fibrinoid necrosis and "acute atherosis" (lipid-laden macrophage accumulation)

Renal:

Glomerular endotheliosis: swelling of glomerular endothelial cells, protein deposits in basement membranes, reduced glomerular filtration
Thickened glomerular tufts
Robbins & Kumar Basic Pathology; Guyton & Hall Medical Physiology

6. Investigations

Investigation	Expected Finding
BP monitoring	≥ 140/90 (gestational) or ≥ 160/110 (severe)
24-hr urine protein	>300 mg/24hr (or spot P:Cr ≥0.3)
CBC + platelets	Thrombocytopenia, hemolysis (schistocytes, low Hb)
LFTs (AST/ALT)	Elevated in HELLP/severe
Serum creatinine	Elevated in severe disease
Uric acid	Elevated (marker of disease severity)
Coagulation profile	Prolonged PT/PTT, low fibrinogen in DIC
Fetal monitoring	NST, BPP, Doppler studies (umbilical artery waveforms)
Neuroimaging (CT/MRI)	If altered consciousness or focal neurology

7. Management

The only definitive treatment is delivery of the baby and placenta, which reverses the placenta-driven pathophysiology. The management strategy balances maternal safety against fetal maturity.

7a. Antihypertensive Therapy

Threshold for treatment:

Diastolic BP >105 mmHg OR systolic BP >160 mmHg requires drug therapy
Persistent BP ≥ 160/110 mmHg for ≥15 minutes is a hypertensive emergency requiring immediate treatment

Drugs safe in pregnancy:

Drug	Route/Dose	Notes
Methyldopa	250 mg PO twice daily	Centrally acting α-agonist; gold standard for chronic use; FDA former category B
Labetalol	100 mg PO twice daily (chronic); 20 mg IV → 40 mg IV (acute)	Combined α/β-blocker; first-line for acute severe HTN
Nifedipine	30 mg PO once daily (slow release)	Ca²⁺ channel blocker; safe; reasonable evidence
Hydralazine	5-10 mg IV/IM, repeat q20 min	Direct vasodilator; used for acute BP control

Drugs CONTRAINDICATED in pregnancy:

ACE inhibitors (fetotoxic: renal agenesis, oligohydramnios, IUGR)
Angiotensin receptor blockers (same mechanism, same fetal risk)

7b. Seizure Prophylaxis and Treatment: Magnesium Sulfate

Magnesium sulfate (MgSO₄) is the cornerstone of eclampsia prevention and treatment:

Has minimal antihypertensive effect
Is the most effective anticonvulsant in eclampsia
Maintains uterine and fetal blood flow (unlike other anticonvulsants)
Used in all women with severe preeclampsia or CNS features (headache, visual disturbance, altered mental status)
Also given postpartum to women with CNS manifestations
Loading dose typically 4-6 g IV over 15-20 min; maintenance 1-2 g/hr

Monitoring for MgSO₄ toxicity:

Loss of patellar reflexes (first sign)
Respiratory depression (>12 breaths/min required)
Antidote: Calcium gluconate 1 g IV

7c. Obstetric Management

Mild preeclampsia at term (≥37 weeks): Deliver
Severe preeclampsia at any gestation: Deliver after maternal stabilization (BP control + MgSO₄)
Preterm severe preeclampsia (<34 weeks): Hospitalization, close monitoring, corticosteroids for fetal lung maturity, attempt to prolong pregnancy if safe
Eclampsia: Stabilize seizures with MgSO₄, control BP, then deliver

7d. Postpartum Care

BP can worsen in the first 48-72 hrs postpartum
~20% of eclampsia cases occur >48 hours after delivery
Women with severe features should remain on MgSO₄ for 24-48 hrs postpartum
BP monitoring for at least 1 week postpartum

8. Complications

Maternal:

Intracranial hemorrhage (leading cause of PIH-related maternal death)
Hepatic rupture
Pulmonary edema
Acute kidney injury
Placental abruption
DIC
Death

Fetal/Neonatal:

Intrauterine growth restriction (IUGR)
Preterm birth
Fetal distress/hypoxia
Intrauterine fetal death
Low birth weight

Long-term (maternal):

Women with preeclampsia have significantly elevated lifetime risk of hypertension, stroke, and cardiovascular disease

9. Prevention

Low-dose aspirin (75-150 mg/day) from 12-16 weeks is recommended in high-risk women (prior preeclampsia, chronic HTN, diabetes, CKD, multiple gestation). It reduces thromboxane A₂ production and has the best evidence for preeclampsia prevention.
Calcium supplementation in calcium-deficient populations
Optimal management of pre-existing conditions (diabetes, HTN, lupus)
Weight optimization before pregnancy

Sources:

Goodman & Gilman's Pharmacological Basis of Therapeutics
Robbins & Kumar Basic Pathology (Robbins Pathology)
Guyton and Hall Textbook of Medical Physiology
Rosen's Emergency Medicine: Concepts and Clinical Practice, 10th Ed.
Creasy & Resnik's Maternal-Fetal Medicine: Principles and Practice

This is a shared conversation. Sign in to Orris to start your own chat.